Back to Search Start Over

HIV-1 tat promotes integrin-mediated HIV transmission to dendritic cells by binding Env spikes and competes neutralization by anti-HIV antibodies.

Authors :
Paolo Monini
Aurelio Cafaro
Indresh K Srivastava
Sonia Moretti
Victoria A Sharma
Claudia Andreini
Chiara Chiozzini
Flavia Ferrantelli
Maria R Pavone Cossut
Antonella Tripiciano
Filomena Nappi
Olimpia Longo
Stefania Bellino
Orietta Picconi
Emanuele Fanales-Belasio
Alessandra Borsetti
Elena Toschi
Ilaria Schiavoni
Ilaria Bacigalupo
Elaine Kan
Leonardo Sernicola
Maria T Maggiorella
Katy Montin
Marco Porcu
Patrizia Leone
Pasqualina Leone
Barbara Collacchi
Clelia Palladino
Barbara Ridolfi
Mario Falchi
Iole Macchia
Jeffrey B Ulmer
Stefano Buttò
Cecilia Sgadari
Mauro Magnani
Maurizio P M Federico
Fausto Titti
Lucia Banci
Franco Dallocchio
Rino Rappuoli
Fabrizio Ensoli
Susan W Barnett
Enrico Garaci
Barbara Ensoli
Source :
PLoS ONE, Vol 7, Iss 11, p e48781 (2012)
Publication Year :
2012
Publisher :
Public Library of Science (PLoS), 2012.

Abstract

Use of Env in HIV vaccine development has been disappointing. Here we show that, in the presence of a biologically active Tat subunit vaccine, a trimeric Env protein prevents in monkeys virus spread from the portal of entry to regional lymph nodes. This appears to be due to specific interactions between Tat and Env spikes that form a novel virus entry complex favoring R5 or X4 virus entry and productive infection of dendritic cells (DCs) via an integrin-mediated pathway. These Tat effects do not require Tat-transactivation activity and are blocked by anti-integrin antibodies (Abs). Productive DC infection promoted by Tat is associated with a highly efficient virus transmission to T cells. In the Tat/Env complex the cysteine-rich region of Tat engages the Env V3 loop, whereas the Tat RGD sequence remains free and directs the virus to integrins present on DCs. V2 loop deletion, which unshields the CCR5 binding region of Env, increases Tat/Env complex stability. Of note, binding of Tat to Env abolishes neutralization of Env entry or infection of DCs by anti-HIV sera lacking anti-Tat Abs, which are seldom present in natural infection. This is reversed, and neutralization further enhanced, by HIV sera containing anti-Tat Abs such as those from asymptomatic or Tat-vaccinated patients, or by sera from the Tat/Env vaccinated monkeys. Thus, both anti-Tat and anti-Env Abs are required for efficient HIV neutralization. These data suggest that the Tat/Env interaction increases HIV acquisition and spreading, as a mechanism evolved by the virus to escape anti-Env neutralizing Abs. This may explain the low effectiveness of Env-based vaccines, which are also unlikely to elicit Abs against new Env epitopes exposed by the Tat/Env interaction. As Tat also binds Envs from different clades, new vaccine strategies should exploit the Tat/Env interaction for both preventative and therapeutic interventions.

Subjects

Subjects :
Medicine
Science

Details

Language :
English
ISSN :
19326203 and 29514347
Volume :
7
Issue :
11
Database :
Directory of Open Access Journals
Journal :
PLoS ONE
Publication Type :
Academic Journal
Accession number :
edsdoj.860549d9bb1144a29514347f7a77ea12
Document Type :
article
Full Text :
https://doi.org/10.1371/journal.pone.0048781